Aprocitentan Patent Expiration
Aprocitentan was first introduced by Idorsia Pharmaceuticals Ltd
Aprocitentan Patents
Given below is the list of patents protecting Aprocitentan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tryvio | US11680058 | Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan | Jul 26, 2038 | Idorsia |
| Tryvio | US11787782 | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | Mar 02, 2038 | Idorsia |
| Tryvio | US10919881 | Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan | Feb 26, 2038 | Idorsia |
| Tryvio | US11174247 | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | Nov 06, 2037 | Idorsia |
| Tryvio | US8324232 | 4-pyrimidinesulfamide derivative | Sep 21, 2029 | Idorsia |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Aprocitentan's patents.
Latest Legal Activities on Aprocitentan's Patents
Given below is the list recent legal activities going on the following patents of Aprocitentan.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Initial letter Re: PTE Application to regulating agency | 16 May, 2024 | US8324232 |
| Patent Term Extension Application under 35 USC 156 Filed | 10 May, 2024 | US8324232 |
| Mail Patent eGrant Notification | 17 Oct, 2023 | US11787782 |
| Patent Issue Date Used in PTA Calculation Critical | 17 Oct, 2023 | US11787782 |
| Recordation of Patent eGrant | 17 Oct, 2023 | US11787782 |
| Recordation of Patent Grant Mailed Critical | 17 Oct, 2023 | US11787782 |
| Email Notification Critical | 17 Oct, 2023 | US11787782 |
| Patent eGrant Notification | 17 Oct, 2023 | US11787782 |
| Email Notification Critical | 28 Sep, 2023 | US11787782 |
| Issue Notification Mailed Critical | 27 Sep, 2023 | US11787782 |
Aprocitentan's Family Patents
